Connect with us

Business

Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19 – FDA.gov

The FDA issued an EUA for two monoclonal antibodies to be administered together for treating mild to moderate COVID-19 in adults and pediatric patients.

Published

on

post featured image
ADVERTISEMENT

For Immediate Release:
November 21, 2020
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older weighing at least 40 kilograms

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

post featured image
Why Oxford’s Covid-19 vaccine could do more for the world than other shots – CNN
post featured image
If there’s no second stimulus check in the next rescue bill, you could still benefit – CNET
post featured image
Tony Hsieh, key figure in downtown Las Vegas revitalization, dies at age 46 – Las Vegas Review-Journal